HRTX Q2 2021 Earnings — Heron Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

HRTXHeron Therapeutics, Inc.

$153M

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$22M-1.0% YoY

Gross Profit

$8M35.3% margin

Operating Income

-$60M-269.4% margin

Net Income

-$61M-271.9% margin

EPS (Diluted)

$-0.62

QoQ Revenue Growth

+12.1%

Cash Flow

Operating Cash Flow

-$63M

Free Cash Flow

-$63M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$404M

Total Liabilities

$244M

Stockholders' Equity

$160M

Cash & Equivalents

$191M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$22M	$23M	-1.0%
Gross Profit	$8M	$14M	-42.0%
Operating Income	-$60M	-$56M	-8.5%
Net Income	-$61M	-$55M	-10.6%

Revenue Segments

C I N V A N T I

$20M88%

S U S T O L

$3M12%